Vivos (RDGL) Return on Sales Growth (3y) (2013 - 2025)
Vivos (RDGL) Return on Sales Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn | 0.00 |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn | 0.00 |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn | 0.00 |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn | 0.00 |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | 0.00 |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 0.00 |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn | 0.00 |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 0.00 |
| 10 | Vivos | 26.71 Mn | 25.15 Mn | -3,105.00 | 65.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.00 |
| Sep 30, 2025 | -227.00 |
| Jun 30, 2025 | 32.00 |
| Mar 31, 2025 | 23.00 |
| Dec 31, 2024 | -89.00 |
| Sep 30, 2024 | -152.00 |
| Dec 31, 2023 | -90.00 |
| Sep 30, 2023 | -76.00 |
| Dec 31, 2022 | 227.00 |
| Sep 30, 2022 | 41.00 |
| Dec 31, 2020 | 1,525.00 |
| Sep 30, 2020 | 845.00 |
| Dec 31, 2019 | 474.00 |
| Sep 30, 2019 | -45.00 |
| Dec 31, 2017 | -832.00 |
| Sep 30, 2017 | -680.00 |
| Jun 30, 2017 | -99.00 |
| Mar 31, 2017 | -26.00 |
| Dec 31, 2016 | -786.00 |
| Sep 30, 2016 | -30.00 |